Government- and industry-funded campaigns for medication disposal do work, but responsibility often falls on local health care organizations to provide education and services.
AMA J Ethics. 2022; 24(10):E971-979. doi:
10.1001/amajethics.2022.971.
Lisa Patel, MD, MESc and Katie E. Lichter, MD, MPH
Health care generates a lot of waste that enters landfills, oceans, and incinerators and adversely affects communities close to waste processing and disposal areas.
AMA J Ethics. 2022; 24(10):E980-985. doi:
10.1001/amajethics.2022.980.
Dumping domestic and international health care waste into the earth’s terra firma and oceans undermine global health equity and the health of vulnerable communities.
AMA J Ethics. 2022; 24(10):E986-993. doi:
10.1001/amajethics.2022.986.
Mismanagement of hospital waste can release harmful, deleterious contaminants into soil, water, and air and can have far-reaching environmental and public relations consequences.
AMA J Ethics. 2022; 24(10):E1013-1021. doi:
10.1001/amajethics.2022.1013.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021; 23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
COVID-19 underscores historical precedent for fear-driven responses that disregard autonomy among persons with low income who are also persons of color.
AMA J Ethics. 2021; 23(11):E840-846. doi:
10.1001/amajethics.2021.840.